関連する実験動画
Updated: Aug 6, 2025

09:01
A Macrophage-Tumor Spheroid Co-Invasion Assay
Published on: January 24, 2025
698
マクロファージは共進化するがんの生態系との接点です
Daan J Kloosterman1, Leila Akkari1
1Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
Cell
|March 16, 2023
まとめ
腫瘍関連マクロファージ (TAM) は,がんにおける重要な免疫細胞です. このレビューでは,TAMが腫瘍の進化や治療抵抗にどのように影響するか調査し,これらの汎用性の高い細胞を標的とした新しい治療戦略を提案しています.
科学分野:
- 免疫学
- 腫瘍学
- 癌 生物学
背景:
- マクロファージは免疫反応と組織修復に関与する 重要な先天的な免疫細胞です
- 腫瘍関連マクロファージ (TAM) は腫瘍の微小環境における重要な役割を果たし,癌の進行に影響を与えます.
- TAMの可塑性は腫瘍に吸収され 癌の生態系の進化を促します
研究 の 目的:
- 固体腫瘍における腫瘍関連マクロファージ (TAM) の表型状態に影響を与える要因をレビューする.
- 自然選択,分散,治療抵抗など,TAMが腫瘍の進化をどのように誘導するかを議論する.
- TAMを標的とした新しい治療戦略を提案する.
主な方法:
- ガンにおけるTAMに関する既存の研究の文献レビュー.
- TAMのフェノタイプの状態と,腫瘍の微小環境内のその調節の分析.
- 現在のTAMターゲティング戦略と将来の研究方向のまとめ
主要な成果:
- TAMは腫瘍の微小環境内の複数の信号によって形成され,その現象型に影響します.
- TAMは腫瘍の進化に重要な役割を果たし,がんの進行と治療抵抗性を促進します.
- TAMの可塑性を理解することは 効果的ながん治療法の開発に不可欠です
結論:
- TAMをターゲットにすることで 癌治療の有望な治療法が生まれます
- 将来の研究は,がんの改善のためにTAM機能を再構築するための新しい戦略に焦点を当てるべきです.
- 次世代の技術を活用することで ガン治療におけるTAMの理解と操作を 進めることができます
関連する概念動画
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Immune Surveillance by NK Cells and Phagocytes
1.6K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K

